EUS Clinical Trials

82 recruitingLast updated: June 21, 2026

There are 82 actively recruiting eus clinical trials across 30 countries. Studies span Not Applicable, Phase 2, Phase 4, Phase 1, Phase 3. Top locations include Montreal, Quebec, Canada, Baltimore, Maryland, United States, Calgary, Alberta, Canada. Updated daily from ClinicalTrials.gov.


EUS Trials at a Glance

82 actively recruiting trials for eus are listed on ClinicalTrialsFinder across 6 cities in 30 countries. The largest study group is Not Applicable with 31 trials, with the heaviest enrollment activity in Montreal, Baltimore, and Calgary. Lead sponsors running eus studies include Todd C. Lee MD MPH FIDSA, Assistance Publique - Hôpitaux de Paris, and Cairo University.

Browse eus trials by phase

Treatments under study

About EUS Clinical Trials

Looking for clinical trials for EUS? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new EUS trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about EUS clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 82 trials

Recruiting

Study of Proteus Syndrome and Related Congenital Disorders

Proteus SyndromePIK3CA Related Overgrowth Spectrum
National Human Genome Research Institute (NHGRI)1,500 enrolled1 locationNCT00001403
Recruiting
Phase 1Phase 2

A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)

Staphylococcus Aureus
AstraZeneca231 enrolled43 locationsNCT06749457
Recruiting
Not Applicable

The Effect of Nasogastric Tube Placement on Complications in Patients With Small Bowel Obstruction - the SBO-TUBE Trial

small bowel obstructionIntestinal Obstruction and Ileus
University Hospital, Linkoeping1,000 enrolled3 locationsNCT07574515
Recruiting
Phase 1

Comparing Single Versus Repeat NMT on the Diversity of the Neonatal Nasal Microbiome

Staphylococcus AureusMicrobial ColonizationNeonatal Infection
Johns Hopkins University175 enrolled1 locationNCT06283355
Recruiting
Phase 2

Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia

Staphylococcus Aureus BacteremiaStaphylococcus Aureus EndocarditisStaphylococcus Aureus Septicemia+1 more
Todd C. Lee MD MPH FIDSA60 enrolled6 locationsNCT04886284
Recruiting
Phase 4

Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia

Staphylococcus Aureus BacteremiaStaphylococcus Aureus EndocarditisStaphylococcus Aureus Septicemia+2 more
Todd C. Lee MD MPH FIDSA300 enrolled16 locationsNCT06637332
Recruiting
Not Applicable

Primary Subtalar Arthrodesis for Calcaneal Fractures

Calcaneus Fracture
Wake Forest University Health Sciences218 enrolled17 locationsNCT06249126
Recruiting

At-Home Bowel Stimulation

Post-Operative Ileus (POI)
The Cleveland Clinic34 enrolled1 locationNCT07574437
Recruiting
Not Applicable

Oral Lactulose for Gastrointestinal Recovery After Complex Appendectomy

Ileus PostoperativeGastrointestinal FunctionComplicated Appendicitis
Nanchong Central Hospital150 enrolled1 locationNCT07589465
Recruiting
Phase 2

MK-7075 (Miransertib) in Proteus Syndrome

Proteus Syndrome
National Human Genome Research Institute (NHGRI)45 enrolled1 locationNCT04316546
Recruiting
Phase 4

Staphylococcus Aureus Network Adaptive Platform Trial

Staphylococcus Aureus Bacteremia
University of Melbourne8,000 enrolled161 locationsNCT05137119
Recruiting
Phase 4

Comparison of Cloxacillin and Benzylpenicillin in Penicillin Susceptible S. Aureus Bacteraemia

Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)Staphylococcus Aureus BacteraemiaStaphylococcal Bacteraemia+1 more
Region Skane420 enrolled1 locationNCT06726395
Recruiting

Rocket Study: A Study to Characterize Biomarkers and Disease Progression in Participants With Pelizaeus-Merzbacher Disease

Pelizaeus-Merzbacher Disease
Ionis Pharmaceuticals, Inc.32 enrolled9 locationsNCT05659901
Recruiting
Not Applicable

Hypoglossal Acupuncture for Dysgeusia in Patients Undergoing Chemotherapy

ChemotherapyCancerAcupuncture+2 more
Universität Duisburg-Essen75 enrolled3 locationsNCT02304913
Recruiting

Autoimmune Blistering Diseases Study

Bullous pemphigoidPemphigus VulgarisPemphigus Foliaceus
University of Pennsylvania150 enrolled3 locationsNCT02753777
Recruiting
Not Applicable

Linezolid Plus Standard of Care

Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)
University Hospital, Basel, Switzerland606 enrolled12 locationsNCT06958835
Recruiting
Phase 4

Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia

Staphylococcus Aureus BacteremiaStaphylococcus Aureus EndocarditisStaphylococcus Aureus Septicemia+3 more
McGill University Health Centre/Research Institute of the McGill University Health Centre300 enrolled1 locationNCT06650501
Recruiting
Phase 4

Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia

Staphylococcus Aureus EndocarditisStaphylococcus Aureus SepticemiaStaphylococcus Aureus Bloodstream Infection
Todd C. Lee MD MPH FIDSA300 enrolled1 locationNCT06650488
Recruiting
Not Applicable

Proof-of-Concept Study of the SNOEZELEN Device on Anxiety Symptoms in Patients Hospitalized for Chemotherapy in a Pediatric Oncology Department

Pediatric CancerSnoezelenSymptomatologie Anxieuse+1 more
Centre Oscar Lambret20 enrolled1 locationNCT07202507
Recruiting
Not Applicable

Performance and Safety Evaluation of Inion CompressOn Screw in Foot and Ankle Surgeries. PMCF Investigation

Medial Malleolus FractureLisfranc InjuryLisfranc Fracture+16 more
Inion Oy125 enrolled1 locationNCT05555459